OTC · APNHY
Healthcare · Drug Manufacturers - Specialty & Generic
$9.64
Up+$0.12 (+1.26%)
Updated Sep 19, 2026, 7:29 PM
SID Score
5.0/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
APNHY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning APNHY.
APNHY research
Company profile and research snapshot.
ASPEN PHARMACRE HL UN/ADR
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 3, 2026
Aspen Pharmacare Holdings Ltd (APNHF) guides to over 50% NHEPS growth in FY27, driven by a raised sterile EBITDA target and a strong net cash position.
SeekingAlpha · Sep 3, 2026
Aspen Pharmacare Holdings Limited (APNHY) Q4 2026 Earnings Call September 3, 2026 2:30 AM EDTCompany ParticipantsRoy CampbellStephen Saad - Group CEO &...
SeekingAlpha · Sep 3, 2026
2026-09-03. The following slide deck was published by Aspen Pharmacare Holdings Limited in conjunction with their 2026 Q4 earnings call.
SeekingAlpha · May 29, 2026
Aspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call May 29, 2026 6:30 AM EDTCompany ParticipantsSibongakonke Nkosi - Investor Relations...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning APNHY.
No results
No recent SID articles mention APNHY.
